Radiography and Pregnancy

pregnant radiation


All radiographers learn in school why radiation is dangerous to a pregnant patient’s fetus, and that it’s very important to screen for pregnant patients allowing the physician to be informed that there is a risk.
Likewise, if you are working as a radiologic technologist, and you get pregnant, it is normal to have some concern about the harmful effects of radiation reaching your baby. Do X-ray techs need pregnancy precautions? Even though the evidence overwhelmingly suggests that a radiographer can continue to safely perform their job without risk to the fetus as long as policies and guidelines are followed, every radiographer should review what the potential effects are.

Pregnant Radiographers and Radiation Workers

Because of the increased health risks to the rapidly developing embryo and fetus, pregnant women can receive no more than 0.5 rem during the entire gestation period. This is 10% of the dose limit that normally applies to radiation workers. Persons under the age of 18 years are also limited to 0.5rem/year.
Some other questions arise regarding when a person who works around radiation becomes pregnant. Laws and policies may vary for different regions. The following recommendations are taken from ICRP 84:

Restricting dose to the conceptus does not mean that it is necessary for pregnant women to avoid work with radiation or radioactive materials completely, or that they must be prevented from entering or working in designated radiation areas. It does, however, imply that the employer should carefully review the exposure conditions of pregnant women. In particular, their working conditions should be such that the probability of high accidental doses and radionuclide intakes is insignificant.

When a medical radiation worker is known to be pregnant, there are three options that are often considered in medical radiation facilities: 1) no change in assigned working duties; 2) change to another area where the radiation exposure may be lower; or 3) change to a job that has essentially no radiation exposure. There is no single correct answer for all situations, and in certain countries there may even be specific regulations. It is desirable to have a discussion with the employee. The worker should be informed of the potential risks, local policies, and recommended dose limits.

Change to a position where there is no radiation exposure is sometimes requested by pregnant workers who realize that risks may be small but do not wish to accept any increased risk. The employer may also arrange for this in order to avoid future difficulties in case the employee delivers a child with a spontaneous congenital abnormality (which occurs at a rate of about 3 in every 100 births). This approach is not required on a radiation protection basis, and it obviously depends on the facility being sufficiently large and flexibility to easily fill the vacated position.

Changing to a position that may have lower ambient exposure is also a possibility. In diagnostic radiology, this may involve transferring a technician from fluoroscopy to CT scanning or some other area where there is less scattered radiation to workers. In nuclear medicine departments, a pregnant technician can be restricted from spending a lot of time in the radiopharmacy or working with radioiodine solutions. In radiotherapy with sealed sources, pregnant technicians or nurses might not participate in manual brachytherapy.

An ethical consideration is involved in both of these last two alternatives since another worker will have to incur additional radiation exposure because a co-worker became pregnant.

There are many situations in which the worker wishes to continue doing the same job, or the employer may depend on her to continue in the same job in order to maintain the level of patient care that the work unit is customarily able to provide. From a radiation protection point of view, this is perfectly acceptable providing the fetal dose can be reasonably accurately estimated and falls within the recommended limit of 1 mGy fetal dose after the pregnancy is declared. It would be reasonable to evaluate the work environment in order to provide assurance that high-dose accidents are unlikely.

The recommended dose limit applies to the fetal dose and it is not directly comparable to the dose measured on a personal dosimeter. A personal dosimeter worn by diagnostic radiology workers may overestimate fetal dose by about a factor of 10 or more. If the dosimeter has been worn outside a lead apron, the measured dose is likely to be about 100 times higher than the fetal dose. Workers in nuclear medicine and radiation therapy usually do not wear lead aprons and are exposed to higher photon energies. In spite of this, fetal doses are not likely to exceed 25 percent of the personal dosimeter measurement.

Finally, factors other than radiation exposure should be considered in evaluating pregnant workers’ activities. In a medical setting there are often requirements for lifting patients and for stooping or bending.

Potential Health Effects of Prenatal Radiation Exposure (Other Than Cancer)

The potential noncancer health risks of concern are summarized in This table, adapted from the US CDC. The indicated doses and times post conception, or gestational age, are approximations.

Table 1: Potential Health Effects (Other Than Cancer) of Prenatal Radiation Exposure
Acute Radiation
Dose* to the
—————————-Time Post Conception (weeks)—————————-

(up to 2)

(2 –7)
(8–15 ) (16 –25) (26 –38)
< 0.05 Gy
(5 rads)†
Noncancer health effects NOT detectable
0.05–0.50 Gy
(5–50 rads)
Incidence of failure to implant may increase slightly, but surviving embryos will probably have no significant (noncancer) health effects • Incidence of major malformations may increase slightly

• Growth retardation possible

• Growth retardation possible

• Reduction in IQ possible (up to 15 points, depending on dose)

• Incidence of severe mental retardation up to 20%, depending on dose

Noncancer health
effects unlikely
> 0.50 Gy
(50 rads)
The expectant mother may be experiencing acute radiation syndrome in this range, depending on her whole-body dose.
Incidence of failure to implant will likely be large,‡ depending on dose, but surviving embryos will probably have no significant (noncancer) health effects • Incidence of miscarriage may increase, depending on dose

• Substantial risk of major malformations such as neurological and motor deficiencies

• Growth retardation likely

• Incidence of miscarriage probably will increase, depending on dose

• Growth retardation likely

• Reduction in IQ possible (> 15 points, depending on dose)

• Incidence of severe mental retardation > 20%, depending on dose

• Incidence of major malformations will probably increase

• Incidence of miscarriage may increase, depending on dose

• Growth retardation possible, depending on dose

• Reduction in IQ possible, depending on dose

• Severe mental retardation possible, depending on dose

• Incidence of major malformations may increase

Incidence of miscarriage and neonatal death will probably increase depending on dose§
Note: This table is intended only as a guide. The indicated doses and times post conception are approximations.

* Acute dose: dose delivered in a short time (usually minutes). Fractionated or chronic doses: doses delivered over time. For fractionated or chronic doses the health effects to the fetus may differ from what is depicted here.
Both the gray (Gy) and the rad are units of absorbed dose and reflect the amount of energy deposited into a mass of tissue (1 Gy = 100 rads). In this document, the absorbed dose is that dose received by the entire fetus (whole-body fetal dose). The referenced absorbed dose levels in this document are assumed to be from beta, gamma, or x-radiation. Neutron or proton radiation produces many of the health effects described herein at lower absorbed dose levels.
A fetal dose of 1 Gy (100 rads) will likely kill 50% of the embryos. The dose necessary to kill 100% of human embryos or fetuses before 18 weeks’ gestation is about 5 Gy (500 rads).
§ For adults, the LD50/60 (the dose necessary to kill 50% of the exposed population in 60 days) is about 3-5 Gy (300-500 rads) and the LD100 (the dose necessary to kill 100% of the exposed population) is around 10 Gy (1000 rads).

Gestational age and radiation dose are important determinants of potential noncancer health effects. The following points are of particular note:

Before about 2 weeks gestation (i.e., the time after conception), the health effect of concern from an exposure of > 0.1 gray (Gy) or 10 rads is the death of the embryo. If the embryo survives, however, radiation-induced noncancer health effects are unlikely, no matter what the radiation dose. Because the embryo is made up of only a few cells, damage to one cell, the progenitor of many other cells, can cause the death of the embryo, and the blastocyst will fail to implant in the uterus. Embryos that survive, however, will exhibit few congenital abnormalities.

In all stages of gestation, radiation-induced noncancer health effects are not detectable for fetal doses below about 0.05 Gy (5 rads). Most researchers agree that a dose of < 0.05 Gy (5 rads) represents no measurable noncancer risk to the embryo or fetus at any stage of gestation. Research on rodents suggests a small risk may exist for malformations, as well as effects on the central nervous system in the 0.05–0.10 Gy (5–10 rads) range for some stages of gestation. However, a practical threshold for congenital effects in the human embryo or fetus is most likely between 0.10–0.20 Gy (10–20 rads).

From about 16 weeks’ gestation to birth, radiation-induced noncancer health effects are unlikely below about 0.50 Gy (50 rads). Although some researchers suggest that a small possibility exists for impaired brain function above 0.10 Gy (10 rads) in the 16- to 25-week stage of gestation, most researchers agree that after about 16 weeks’ gestation, the threshold for congenital effects in the human embryo or fetus is approximately 0.50–0.70 Gy (50–70 rads).
The normal rate of failure of a blastocyst to implant in the uterine wall is high, perhaps 30%–50%. After the embryo implants there, however, the miscarriage rate decreases to about 15% for the rest of the pregnancy, and the cells begin differentiating into various stem cells that eventually form all of the organs in the body.

Ionizing radiation can impair the developmental events that occur at exposure. Also, atomic bomb survivor data show a permanent retardation of physical growth with increasing dose, particularly above 1 Gy (100 rads). This retardation of growth is most pronounced when the exposure occurs in the first 13 weeks of gestation. Atomic bomb survivor data suggest about a 3%–4% reduction of height at age 18 when the dose is greater than 1 Gy (100 rads).
Radiation may significantly affect brain development among persons exposed at 8–15 weeks’ gestation. Atomic bomb survivor data indicate that, in this stage, the average IQ loss is approximately 25–31 points per Gy (per 100 rads) above 0.1 Gy (10 rads), and the risk for severe mental retardation is approximately 40% per Gy (per 100 rads), above 0.1 Gy (10 rads). For studies of the atomic bomb victims, severe mental retardation was related not to IQ, but to clinical observation: “unable to perform simple calculations, to make simple conversation, to care for himself or herself, or if he or she was completely unmanageable or had been institutionalized”. This corresponds to an IQ less than 50 (0.4% prevalence in the unexposed population).
The central nervous system is less sensitive in the 16- to 25-week stage of gestation. However, the same effects seen in the 8- to 15-week stage also may occur at this time at higher doses. In the 16- to 25-week stage the average IQ loss is approximately 13–21 points per Gy (per 100 rads) at doses above 0.7 Gy (70 rads), and the risk for severe mental retardation is approximately 9% per Gy (per 100 rads) above 0.7 Gy (70 rads). Also, if internal uptake of radioactive iodine occurs in this stage, the long-term health consequences to the thyroid of the offspring should be considered. The fetal thyroid is very active in this stage, and if the mother ingests or inhales radioactive iodine, it will concentrate in the fetal thyroid as well as in the mother’s thyroid.
Beyond about 26 weeks, the fetus is less sensitive to the noncancer health effects of radiation exposure than in any other stage of gestation. However, at doses above 1 Gy (100 rads) the risks for miscarriage and neonatal death (i.e., infant death within 28 days after birth, including stillbirth) increases.
The CDC concludes that fetal sensitivity to radiation-induced health effects is highly dependent on fetal dose, and the mother’s abdomen provides some protection from external sources of ionizing radiation. In addition, noncancer health effects depend on gestational age.



Read more about this and other subjects and get 12 Category A ARRT CE Credits in the X-Ray CE Course “Understanding Ionizing Radiation and Protection”

Read More

Thank you for choosing
Have any questions? Want to tell us how we are doing? Maybe you have suggestions on how to make our courses or site even better? We'd love to hear from you, just give us a text or call at 657-222-0777

All content on this site Copyright © 2019 XRC LLC All rights reserved. 848 N. Rainbow Blvd. #4152 - Las Vegas, NV 89107 657-222-0111 


*  "ARRT© is a registered trademark owned by The American Registry of Radiologic Technologists. Although our courses are accepted by the ARRT for credit, as with all other online CE providers this website is not directly licensed by, endorsed by, or affiliated with The American Registry of Radiologic Technologists.